Status:
UNKNOWN
Eucaloric Ketogenic Diet in COVID-19 Cytokine Storm Syndrome
Lead Sponsor:
Ospedale Policlinico San Martino
Conditions:
Covid19
Ketogenic Dieting
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Covid 19 pandemia is causing millions of deaths worldwide. To date, the evidence gathered suggests that the subgroup of patients who present the most serious clinical feature of COVID-19 could have a ...
Eligibility Criteria
Inclusion
- documented clinical diagnosis of COVID-19 supported by clinical features and by the positivity to at least one pharyngeal swab
- age ≥18 years
- informed written consent
Exclusion
- Type I diabetes
- Type II diabetes in therapy with insulin, sulphonylureas, repaglinide, GLP-1 analogues, SGLT2 inhibitors
- Recent acute cardiovascular event (within a month)
- Food allergies to diet components
- Any metabolic disorder capable of influencing gluconeogenesis
- Clinical history of severe hypertriglyceridemia with or without pancreatitis
- Pregnancy and/or breastfeeding
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 30 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04492228
Start Date
September 1 2020
End Date
May 30 2021
Last Update
September 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samir Giuseppe Sukkar
Genova, Italy, 16132